Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene

[1]  M. Altini,et al.  Oral candidosis in relation to oral immunity. , 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  P. Chrobak,et al.  HIV Nef Expression Favors the Relative Preservation of CD4+ T Regulatory Cells That Retain Some Important Suppressive Functions , 2014, The Journal of Immunology.

[3]  P. Villard,et al.  Activation of the NFκB Pathway Enhances AhR Expression in Intestinal Caco-2 Cells , 2013, ISRN toxicology.

[4]  Boping Zhou,et al.  Imbalances of Gut-Homing CD4+ T-Cell Subsets in HIV-1–Infected Chinese Patients , 2013, Journal of acquired immune deficiency syndromes.

[5]  R. Kaul,et al.  Mucosal Th17 Cell Function Is Altered during HIV Infection and Is an Independent Predictor of Systemic Immune Activation , 2013, The Journal of Immunology.

[6]  J. Arthos,et al.  Preferential HIV Infection of CCR6+ Th17 Cells Is Associated with Higher Levels of Virus Receptor Expression and Lack of CCR5 Ligands , 2013, Journal of Virology.

[7]  C. Rouzioux,et al.  The Th17/Treg Ratio, IL-1RA and sCD14 Levels in Primary HIV Infection Predict the T-cell Activation Set Point in the Absence of Systemic Microbial Translocation , 2013, PLoS pathogens.

[8]  S. Bixler,et al.  Loss and Dysregulation of Th17 Cells during HIV Infection , 2013, Clinical & developmental immunology.

[9]  S. Leibundgut-Landmann,et al.  Cutting Edge: IL-17–Secreting Innate Lymphoid Cells Are Essential for Host Defense against Fungal Infection , 2013, The Journal of Immunology.

[10]  H. Salomón,et al.  Analysis of Suppressor and Non-Suppressor FOXP3+ T Cells in HIV-1-Infected Patients , 2012, PloS one.

[11]  R. K. Reeves,et al.  Functional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection , 2012, Front. Immun..

[12]  M. McGeachy,et al.  Microbial-Induced Th17: Superhero or Supervillain? , 2012, The Journal of Immunology.

[13]  Jerome H. Kim,et al.  Distinct gene expression profiles associated with the susceptibility of pathogen-specific CD4+ T cells to HIV-1 infection , 2012, Retrovirology.

[14]  A. Parmigiani,et al.  The role of interleukin-21 in HIV infection. , 2012, Cytokine & growth factor reviews.

[15]  A. Cassone,et al.  Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders , 2012, AIDS.

[16]  C. Chougnet,et al.  Homeostasis and Function of Regulatory T Cells in HIV/SIV Infection , 2012, Journal of Virology.

[17]  A. Lackner,et al.  IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques , 2012, Mucosal Immunology.

[18]  C. Akdis,et al.  TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. , 2012, The Journal of allergy and clinical immunology.

[19]  S. Gaffen,et al.  Th17 cells in immunity to Candida albicans. , 2012, Cell host & microbe.

[20]  A. Rivera,et al.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation. , 2012, Cytokine.

[21]  Yan Luo,et al.  A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients. , 2012, AIDS research and human retroviruses.

[22]  C. Chougnet,et al.  HIV-Induced T-Cell Activation/Exhaustion in Rectal Mucosa Is Controlled Only Partially by Antiretroviral Treatment , 2012, PloS one.

[23]  W. Wurst,et al.  Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia , 2012, Nature Communications.

[24]  M. Lederman,et al.  Frequencies of FoxP3+ naïve T cells are related to both viral load and naïve T cell proliferation responses in HIV disease , 2011, Journal of leukocyte biology.

[25]  J. Ring,et al.  IL‐22 and TNF‐α represent a key cytokine combination for epidermal integrity during infection with Candida albicans , 2011, European journal of immunology.

[26]  B. Grimbacher,et al.  Mucosal antifungal defence: IL‐17 signalling takes centre stage , 2011, Immunology and cell biology.

[27]  Changyou Wu,et al.  Interleukin‐21 induces the differentiation of human Tc22 cells via phosphorylation of signal transducers and activators of transcription , 2011, Immunology.

[28]  Y. Iwakura,et al.  The role of Syk/CARD9 coupled C-type lectins in antifungal immunity , 2010, European journal of immunology.

[29]  J. Hauber,et al.  Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+ T Regulatory Cells Correlates with Progressive Disease , 2010, Journal of Virology.

[30]  M. Swain,et al.  Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis. , 2010, The American journal of pathology.

[31]  J. Saunus,et al.  Early activation of the interleukin-23-17 axis in a murine model of oropharyngeal candidiasis. , 2010, Molecular oral microbiology.

[32]  P. Chrobak,et al.  HIV-1 Nef Disrupts Maturation of CD4+ T Cells through CD4/Lck Modulation , 2010, The Journal of Immunology.

[33]  M. Netea,et al.  Innate immune mechanisms for recognition and uptake of Candida species. , 2010, Trends in immunology.

[34]  S. Gaffen,et al.  Host responses to Candida albicans: Th17 cells and mucosal candidiasis. , 2010, Microbes and infection.

[35]  A. Shafferman,et al.  The Involvement of IL-17A in the Murine Response to Sub-Lethal Inhalational Infection with Francisella tularensis , 2010, PloS one.

[36]  J. Renauld,et al.  IL-22 defines a novel immune pathway of antifungal resistance , 2010, Mucosal Immunology.

[37]  M. Schaller,et al.  Epithelial Cells and Innate Antifungal Defense , 2010, Journal of dental research.

[38]  W. Borkowsky,et al.  Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. , 2010, The Journal of infectious diseases.

[39]  D. Unutmaz,et al.  Th17 cells and HIV infection , 2010, Current opinion in HIV and AIDS.

[40]  P. Klenerman,et al.  HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells , 2010, AIDS.

[41]  R. Sabat,et al.  Biology of interleukin-22 , 2010, Seminars in Immunopathology.

[42]  J. Routy,et al.  Peripheral Blood CCR4+CCR6+ and CXCR3+CCR6+ CD4+ T Cells Are Highly Permissive to HIV-1 Infection , 2009, The Journal of Immunology.

[43]  A. Peck,et al.  Precarious Balance: Th17 Cells in Host Defense , 2009, Infection and Immunity.

[44]  N. L. Sharma,et al.  Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts , 2009, International journal of STD & AIDS.

[45]  W. Nacken,et al.  Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans , 2009, PLoS pathogens.

[46]  P. Taylor,et al.  Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection , 2009, The Journal of experimental medicine.

[47]  F. Kahabuka,et al.  Oral manifestations among people living with HIV/AIDS in Tanzania. , 2009, International Dental Journal.

[48]  M. Marquis,et al.  Selective Expression of Human Immunodeficiency Virus Nef in Specific Immune Cell Populations of Transgenic Mice Is Associated with Distinct AIDS-Like Phenotypes , 2009, Journal of Virology.

[49]  S. Gaffen,et al.  Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa , 2009, Mucosal Immunology.

[50]  Shao-Cong Sun,et al.  Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK. , 2009, Blood.

[51]  S. Schreiber,et al.  The expression of the β-defensins hBD-2 and hBD-3 is differentially regulated by NF-κB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis , 2009, BMC Immunology.

[52]  Changyou Wu,et al.  Memory IL‐22‐producing CD4+ T cells specific for Candida albicans are present in humans , 2009, European journal of immunology.

[53]  Irma Joosten,et al.  The macrophage mannose receptor induces IL-17 in response to Candida albicans. , 2009, Cell host & microbe.

[54]  S. Gaffen,et al.  Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis , 2009, The Journal of experimental medicine.

[55]  A. Casadevall,et al.  Rethinking T cell immunity in oropharyngeal candidiasis , 2009, The Journal of experimental medicine.

[56]  J. Ring,et al.  Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. , 2008, The Journal of investigative dermatology.

[57]  J. Kolls,et al.  Cytokine-mediated regulation of antimicrobial proteins , 2008, Nature Reviews Immunology.

[58]  D. Douek,et al.  Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. , 2008, Blood.

[59]  R. Siliciano,et al.  Severe Depletion of CD4+ CD25+ Regulatory T Cells from the Intestinal Lamina Propria but Not Peripheral Blood or Lymph Nodes during Acute Simian Immunodeficiency Virus Infection , 2007, Journal of Virology.

[60]  A. D. Panopoulos,et al.  Essential autocrine regulation by IL-21 in the generation of inflammatory T cells , 2007, Nature.

[61]  J. Ruland,et al.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.

[62]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[63]  L. Fouser,et al.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.

[64]  D. Mercante,et al.  Assessment of the Association Between HIV Viral Load and CD4 Cell Count on the Occurrence of Oropharyngeal Candidiasis in HIV-Infected Patients , 2006, Journal of acquired immune deficiency syndromes.

[65]  M. Marquis,et al.  Altered CD4+ T Cell Phenotype and Function Determine the Susceptibility to Mucosal Candidiasis in Transgenic Mice Expressing HIV-11 , 2006, The Journal of Immunology.

[66]  P. Fidel Candida-Host Interactions in HIV Disease: Relationships in Oropharyngeal Candidiasis , 2006, Advances in dental research.

[67]  K. Ranganathan,et al.  Oral Lesions in HIV Infection in Developing Countries: an Overview , 2006, Advances in dental research.

[68]  M. Marquis,et al.  CD8+ T Cells but Not Polymorphonuclear Leukocytes Are Required To Limit Chronic Oral Carriage of Candida albicans in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 , 2006, Infection and Immunity.

[69]  P. Jolicoeur,et al.  Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection , 2004, Clinical Microbiology Reviews.

[70]  K. Asadullah,et al.  IL-22 increases the innate immunity of tissues. , 2004, Immunity.

[71]  T. Mak,et al.  CD4+ T Cells from CD4C/HIVNef Transgenic Mice Show Enhanced Activation In Vivo with Impaired Proliferation In Vitro but Are Dispensable for the Development of a Severe AIDS-Like Organ Disease , 2004, Journal of Virology.

[72]  M. Lederman,et al.  Impaired TCR-Mediated Induction of Ki67 by Naive CD4+ T Cells Is Only Occasionally Corrected by Exogenous IL-2 in HIV-1 Infection 1 , 2003, The Journal of Immunology.

[73]  P. Jolicoeur,et al.  The AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Accumulation of Immature CD11bHi Dendritic Cells , 2003, Journal of Virology.

[74]  Bharat B. Aggarwal,et al.  Exogenous Nef Protein Activates NF-κB, AP-1, and c-Jun N-Terminal Kinase and Stimulates HIV Transcription in Promonocytic Cells , 2003, The Journal of Biological Chemistry.

[75]  A. Satoskar,et al.  Interleukin 21 Is a T Helper (Th) Cell 2 Cytokine that Specifically Inhibits the Differentiation of Naive Th Cells into Interferon γ–producing Th1 Cells , 2002, The Journal of experimental medicine.

[76]  P. Jolicoeur,et al.  Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system. , 2002, The American journal of pathology.

[77]  P. Jolicoeur,et al.  Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1. , 2002, The Journal of infectious diseases.

[78]  G. Paré,et al.  The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6. , 2001, Immunity.

[79]  Z. Kurago,et al.  A comparison of salivary calprotectin levels in subjects with and without oral candidiasis. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[80]  S. Challacombe,et al.  Salivary calprotectin levels are raised in patients with oral candidiasis or Sjögren's syndrome but decreased by HIV infection. , 2001, Oral microbiology and immunology.

[81]  H. Friess,et al.  IL-17 Stimulates Intraperitoneal Neutrophil Infiltration Through the Release of GROα Chemokine from Mesothelial Cells1 , 2000, The Journal of Immunology.

[82]  J. Rex,et al.  Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[83]  A. Guimond,et al.  Nef Harbors a Major Determinant of Pathogenicity for an AIDS-like Disease Induced by HIV-1 in Transgenic Mice , 1998, Cell.

[84]  M. Roederer,et al.  CD8 naive T cell counts decrease progressively in HIV-infected adults. , 1995, The Journal of clinical investigation.

[85]  K. Stoltze,et al.  Oral candidiasis and immune status of HIV-infected patients. , 1994, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[86]  L. Trudel,et al.  Experimental oral candidosis in the mouse: microbiologic and histologic aspects. , 1990, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[87]  L. Samaranayake,et al.  Oral candidiasis and human immunodeficiency virus infection. , 1989, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[88]  J. Castilla,et al.  Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.